Issue navigation
Volume 28, Issue 2, February 2022
Leading Off
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis
Jeffrey S Hyams and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 151–160, https://doi.org/10.1093/ibd/izab061
Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model
Laura A Johnson and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 161–175, https://doi.org/10.1093/ibd/izab166
Clinical Research
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
Christina Santella and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 176–182, https://doi.org/10.1093/ibd/izab092
Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission
Luca Scarallo and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 183–191, https://doi.org/10.1093/ibd/izab046
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Laura E Raffals and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 192–199, https://doi.org/10.1093/ibd/izab071
Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
Kunio Asonuma and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 200–207, https://doi.org/10.1093/ibd/izab062
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases
Claire Liefferinckx and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 208–217, https://doi.org/10.1093/ibd/izab042
Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn’s Disease
Hadrien Alric and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 218–225, https://doi.org/10.1093/ibd/izab060
Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study
Jeffrey D McCurdy and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 226–233, https://doi.org/10.1093/ibd/izab086
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program
Bruce E Sands and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 234–245, https://doi.org/10.1093/ibd/izab056
Basic Science Research
Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn’s Disease
Aito Ueno and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 246–258, https://doi.org/10.1093/ibd/izab157
Characterization of Skeletal Phenotype and Associated Mechanisms With Chronic Intestinal Inflammation in the Winnie Mouse Model of Spontaneous Chronic Colitis
Ahmed Al Saedi and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 259–272, https://doi.org/10.1093/ibd/izab174
Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis
Yan Xu and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 273–288, https://doi.org/10.1093/ibd/izab188
Clinical Review
Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance
Benjamin Click and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 289–298, https://doi.org/10.1093/ibd/izab081
Basic Science Review
The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis
Babajide A Ojo and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 299–308, https://doi.org/10.1093/ibd/izab161
Clinical Brief Reports
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn’s Disease
Scott David Lee and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 309–313, https://doi.org/10.1093/ibd/izab176
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry
Ryan C Ungaro and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 314–317, https://doi.org/10.1093/ibd/izab184
Basic Science Brief Report
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice
David M Alvarado and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 318–321, https://doi.org/10.1093/ibd/izab274
Invited Editorials
Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working
Jeremy Adler and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 322–324, https://doi.org/10.1093/ibd/izab047
The Difficulty of Distal Crohn’s Disease and the Utility of Diverting Stomas
Nicole Elizabeth Kiefer Wieghard
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 325–326, https://doi.org/10.1093/ibd/izab146
Letters to the Editor
Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn’s Disease
Sheeva Johnson and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Page e17, https://doi.org/10.1093/ibd/izab210
Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum
Yusuke Matsune and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages e18–e20, https://doi.org/10.1093/ibd/izab222
Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19
Xianqiang Yu
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Page e21, https://doi.org/10.1093/ibd/izab223
Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation—Causal Link or Only Temporal Coincidence?
Na Wu and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages e22–e23, https://doi.org/10.1093/ibd/izab229
Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib
Shubhra Mishra and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Page e24, https://doi.org/10.1093/ibd/izab234
Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn’s Disease Under Anti-TNF Therapy
Parna Moghadam and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages e25–e26, https://doi.org/10.1093/ibd/izab235
Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study
Xiaoyu Gu and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages e27–e28, https://doi.org/10.1093/ibd/izab240
Advertisement
Advertisement